CDTX•benzinga•
Cidara Therapeutics Announces Initiation Of Phase 2a Human Viral Challenge Trial To Evaluate CD388 For Universal Prevention Of Influenza
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 13, 2022 by benzinga